ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Ustekinumab Biosimilars Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-30C17798
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Ustekinumab Biosimilars Market Research Report 2024
BUY CHAPTERS

Global Ustekinumab Biosimilars Market Research Report 2024

Code: QYRE-Auto-30C17798
Report
August 2024
Pages:87
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
TEVA
Sandoz Inc
SAMSUNG
Amgen Inc
Samsung Bioepis
Biocon Biologics
Celltrion
Qyuns Therapeutics
Bio-Thera Solutions
Huadong Medicine

Ustekinumab Biosimilars Market

Ustekinumab biosimilars are drugs designed to closely replicate the structure and function of ustekinumab,a monoclonal antibody used to treat autoimmune conditions like psoriasis,Crohn's disease,and psoriatic arthritis.
The global Ustekinumab Biosimilars market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Ustekinumab Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Ustekinumab Biosimilars is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Ustekinumab Biosimilars include Teva, Amgen, Samsung Bioepis, Sandoz, Biocon Biologics, Celltrion, Qyuns Therapeutics, Bio-Thera Solutions, Huadong Medicine, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Ustekinumab Biosimilars, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ustekinumab Biosimilars.
The Ustekinumab Biosimilars market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Ustekinumab Biosimilars market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Ustekinumab Biosimilars manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Ustekinumab Biosimilars Market Report

Report Metric Details
Report Name Ustekinumab Biosimilars Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Teva, Amgen, Samsung Bioepis, Sandoz, Biocon Biologics, Celltrion, Qyuns Therapeutics, Bio-Thera Solutions, Huadong Medicine
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Ustekinumab Biosimilars manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Ustekinumab Biosimilars in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Ustekinumab Biosimilars Market report?

Ans: The main players in the Ustekinumab Biosimilars Market are Teva, Amgen, Samsung Bioepis, Sandoz, Biocon Biologics, Celltrion, Qyuns Therapeutics, Bio-Thera Solutions, Huadong Medicine

What are the Application segmentation covered in the Ustekinumab Biosimilars Market report?

Ans: The Applications covered in the Ustekinumab Biosimilars Market report are Crohn's Disease, Ulcerative Colitis, Plaque Psoriasis, Psoriatic Arthritis, Other

What are the Type segmentation covered in the Ustekinumab Biosimilars Market report?

Ans: The Types covered in the Ustekinumab Biosimilars Market report are Subcutaneous Injection, Intravenous Infusion

Recommended Reports

Autoimmune Treatments

Inflammatory Bowel Disease

Biosimilars & Immunology

1 Ustekinumab Biosimilars Market Overview
1.1 Product Definition
1.2 Ustekinumab Biosimilars by Type
1.2.1 Global Ustekinumab Biosimilars Market Value Comparison by Type (2024-2030)
1.2.2 Subcutaneous Injection
1.2.3 Intravenous Infusion
1.3 Ustekinumab Biosimilars by Application
1.3.1 Global Ustekinumab Biosimilars Market Value by Application (2024-2030)
1.3.2 Crohn's Disease
1.3.3 Ulcerative Colitis
1.3.4 Plaque Psoriasis
1.3.5 Psoriatic Arthritis
1.3.6 Other
1.4 Global Ustekinumab Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Ustekinumab Biosimilars Revenue 2019-2030
1.4.2 Global Ustekinumab Biosimilars Sales 2019-2030
1.4.3 Global Ustekinumab Biosimilars Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Ustekinumab Biosimilars Market Competition by Manufacturers
2.1 Global Ustekinumab Biosimilars Sales Market Share by Manufacturers (2019-2024)
2.2 Global Ustekinumab Biosimilars Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Ustekinumab Biosimilars Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Ustekinumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Ustekinumab Biosimilars, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Ustekinumab Biosimilars, Product Type & Application
2.7 Global Key Manufacturers of Ustekinumab Biosimilars, Date of Enter into This Industry
2.8 Global Ustekinumab Biosimilars Market Competitive Situation and Trends
2.8.1 Global Ustekinumab Biosimilars Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Ustekinumab Biosimilars Players Market Share by Revenue
2.8.3 Global Ustekinumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Ustekinumab Biosimilars Market Scenario by Region
3.1 Global Ustekinumab Biosimilars Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Ustekinumab Biosimilars Sales by Region: 2019-2030
3.2.1 Global Ustekinumab Biosimilars Sales by Region: 2019-2024
3.2.2 Global Ustekinumab Biosimilars Sales by Region: 2025-2030
3.3 Global Ustekinumab Biosimilars Revenue by Region: 2019-2030
3.3.1 Global Ustekinumab Biosimilars Revenue by Region: 2019-2024
3.3.2 Global Ustekinumab Biosimilars Revenue by Region: 2025-2030
3.4 North America Ustekinumab Biosimilars Market Facts & Figures by Country
3.4.1 North America Ustekinumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Ustekinumab Biosimilars Sales by Country (2019-2030)
3.4.3 North America Ustekinumab Biosimilars Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Ustekinumab Biosimilars Market Facts & Figures by Country
3.5.1 Europe Ustekinumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Ustekinumab Biosimilars Sales by Country (2019-2030)
3.5.3 Europe Ustekinumab Biosimilars Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Ustekinumab Biosimilars Market Facts & Figures by Region
3.6.1 Asia Pacific Ustekinumab Biosimilars Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Ustekinumab Biosimilars Sales by Region (2019-2030)
3.6.3 Asia Pacific Ustekinumab Biosimilars Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Ustekinumab Biosimilars Market Facts & Figures by Country
3.7.1 Latin America Ustekinumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Ustekinumab Biosimilars Sales by Country (2019-2030)
3.7.3 Latin America Ustekinumab Biosimilars Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Ustekinumab Biosimilars Market Facts & Figures by Country
3.8.1 Middle East and Africa Ustekinumab Biosimilars Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Ustekinumab Biosimilars Sales by Country (2019-2030)
3.8.3 Middle East and Africa Ustekinumab Biosimilars Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Ustekinumab Biosimilars Sales by Type (2019-2030)
4.1.1 Global Ustekinumab Biosimilars Sales by Type (2019-2024)
4.1.2 Global Ustekinumab Biosimilars Sales by Type (2025-2030)
4.1.3 Global Ustekinumab Biosimilars Sales Market Share by Type (2019-2030)
4.2 Global Ustekinumab Biosimilars Revenue by Type (2019-2030)
4.2.1 Global Ustekinumab Biosimilars Revenue by Type (2019-2024)
4.2.2 Global Ustekinumab Biosimilars Revenue by Type (2025-2030)
4.2.3 Global Ustekinumab Biosimilars Revenue Market Share by Type (2019-2030)
4.3 Global Ustekinumab Biosimilars Price by Type (2019-2030)
5 Segment by Application
5.1 Global Ustekinumab Biosimilars Sales by Application (2019-2030)
5.1.1 Global Ustekinumab Biosimilars Sales by Application (2019-2024)
5.1.2 Global Ustekinumab Biosimilars Sales by Application (2025-2030)
5.1.3 Global Ustekinumab Biosimilars Sales Market Share by Application (2019-2030)
5.2 Global Ustekinumab Biosimilars Revenue by Application (2019-2030)
5.2.1 Global Ustekinumab Biosimilars Revenue by Application (2019-2024)
5.2.2 Global Ustekinumab Biosimilars Revenue by Application (2025-2030)
5.2.3 Global Ustekinumab Biosimilars Revenue Market Share by Application (2019-2030)
5.3 Global Ustekinumab Biosimilars Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Company Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Teva Ustekinumab Biosimilars Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Amgen
6.2.1 Amgen Company Information
6.2.2 Amgen Description and Business Overview
6.2.3 Amgen Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Amgen Ustekinumab Biosimilars Product Portfolio
6.2.5 Amgen Recent Developments/Updates
6.3 Samsung Bioepis
6.3.1 Samsung Bioepis Company Information
6.3.2 Samsung Bioepis Description and Business Overview
6.3.3 Samsung Bioepis Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Samsung Bioepis Ustekinumab Biosimilars Product Portfolio
6.3.5 Samsung Bioepis Recent Developments/Updates
6.4 Sandoz
6.4.1 Sandoz Company Information
6.4.2 Sandoz Description and Business Overview
6.4.3 Sandoz Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sandoz Ustekinumab Biosimilars Product Portfolio
6.4.5 Sandoz Recent Developments/Updates
6.5 Biocon Biologics
6.5.1 Biocon Biologics Company Information
6.5.2 Biocon Biologics Description and Business Overview
6.5.3 Biocon Biologics Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Biocon Biologics Ustekinumab Biosimilars Product Portfolio
6.5.5 Biocon Biologics Recent Developments/Updates
6.6 Celltrion
6.6.1 Celltrion Company Information
6.6.2 Celltrion Description and Business Overview
6.6.3 Celltrion Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Celltrion Ustekinumab Biosimilars Product Portfolio
6.6.5 Celltrion Recent Developments/Updates
6.7 Qyuns Therapeutics
6.7.1 Qyuns Therapeutics Company Information
6.7.2 Qyuns Therapeutics Description and Business Overview
6.7.3 Qyuns Therapeutics Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Qyuns Therapeutics Ustekinumab Biosimilars Product Portfolio
6.7.5 Qyuns Therapeutics Recent Developments/Updates
6.8 Bio-Thera Solutions
6.8.1 Bio-Thera Solutions Company Information
6.8.2 Bio-Thera Solutions Description and Business Overview
6.8.3 Bio-Thera Solutions Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bio-Thera Solutions Ustekinumab Biosimilars Product Portfolio
6.8.5 Bio-Thera Solutions Recent Developments/Updates
6.9 Huadong Medicine
6.9.1 Huadong Medicine Company Information
6.9.2 Huadong Medicine Description and Business Overview
6.9.3 Huadong Medicine Ustekinumab Biosimilars Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Huadong Medicine Ustekinumab Biosimilars Product Portfolio
6.9.5 Huadong Medicine Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Ustekinumab Biosimilars Industry Chain Analysis
7.2 Ustekinumab Biosimilars Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Ustekinumab Biosimilars Production Mode & Process
7.4 Ustekinumab Biosimilars Sales and Marketing
7.4.1 Ustekinumab Biosimilars Sales Channels
7.4.2 Ustekinumab Biosimilars Distributors
7.5 Ustekinumab Biosimilars Customers
8 Ustekinumab Biosimilars Market Dynamics
8.1 Ustekinumab Biosimilars Industry Trends
8.2 Ustekinumab Biosimilars Market Drivers
8.3 Ustekinumab Biosimilars Market Challenges
8.4 Ustekinumab Biosimilars Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
TEVA
Sandoz Inc
SAMSUNG
Amgen Inc
Samsung Bioepis
Biocon Biologics
Celltrion
Qyuns Therapeutics
Bio-Thera Solutions
Huadong Medicine
List of Tables
 Table 1. Global Ustekinumab Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Ustekinumab Biosimilars Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Ustekinumab Biosimilars Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Ustekinumab Biosimilars Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Ustekinumab Biosimilars Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Ustekinumab Biosimilars Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Ustekinumab Biosimilars Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Ustekinumab Biosimilars Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Ustekinumab Biosimilars, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Ustekinumab Biosimilars, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Ustekinumab Biosimilars, Product Type & Application
 Table 12. Global Key Manufacturers of Ustekinumab Biosimilars, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Ustekinumab Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ustekinumab Biosimilars as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Ustekinumab Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Ustekinumab Biosimilars Sales by Region (2019-2024) & (K Units)
 Table 18. Global Ustekinumab Biosimilars Sales Market Share by Region (2019-2024)
 Table 19. Global Ustekinumab Biosimilars Sales by Region (2025-2030) & (K Units)
 Table 20. Global Ustekinumab Biosimilars Sales Market Share by Region (2025-2030)
 Table 21. Global Ustekinumab Biosimilars Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Ustekinumab Biosimilars Revenue Market Share by Region (2019-2024)
 Table 23. Global Ustekinumab Biosimilars Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Ustekinumab Biosimilars Revenue Market Share by Region (2025-2030)
 Table 25. North America Ustekinumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Ustekinumab Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 27. North America Ustekinumab Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 28. North America Ustekinumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Ustekinumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Ustekinumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Ustekinumab Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Ustekinumab Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Ustekinumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Ustekinumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Ustekinumab Biosimilars Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Ustekinumab Biosimilars Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Ustekinumab Biosimilars Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Ustekinumab Biosimilars Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Ustekinumab Biosimilars Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Ustekinumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Ustekinumab Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Ustekinumab Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Ustekinumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Ustekinumab Biosimilars Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Ustekinumab Biosimilars Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Ustekinumab Biosimilars Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Ustekinumab Biosimilars Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Ustekinumab Biosimilars Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Ustekinumab Biosimilars Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Ustekinumab Biosimilars Sales (K Units) by Type (2019-2024)
 Table 51. Global Ustekinumab Biosimilars Sales (K Units) by Type (2025-2030)
 Table 52. Global Ustekinumab Biosimilars Sales Market Share by Type (2019-2024)
 Table 53. Global Ustekinumab Biosimilars Sales Market Share by Type (2025-2030)
 Table 54. Global Ustekinumab Biosimilars Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Ustekinumab Biosimilars Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Ustekinumab Biosimilars Revenue Market Share by Type (2019-2024)
 Table 57. Global Ustekinumab Biosimilars Revenue Market Share by Type (2025-2030)
 Table 58. Global Ustekinumab Biosimilars Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Ustekinumab Biosimilars Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Ustekinumab Biosimilars Sales (K Units) by Application (2019-2024)
 Table 61. Global Ustekinumab Biosimilars Sales (K Units) by Application (2025-2030)
 Table 62. Global Ustekinumab Biosimilars Sales Market Share by Application (2019-2024)
 Table 63. Global Ustekinumab Biosimilars Sales Market Share by Application (2025-2030)
 Table 64. Global Ustekinumab Biosimilars Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Ustekinumab Biosimilars Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Ustekinumab Biosimilars Revenue Market Share by Application (2019-2024)
 Table 67. Global Ustekinumab Biosimilars Revenue Market Share by Application (2025-2030)
 Table 68. Global Ustekinumab Biosimilars Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Ustekinumab Biosimilars Price (US$/Unit) by Application (2025-2030)
 Table 70. Teva Company Information
 Table 71. Teva Description and Business Overview
 Table 72. Teva Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Teva Ustekinumab Biosimilars Product
 Table 74. Teva Recent Developments/Updates
 Table 75. Amgen Company Information
 Table 76. Amgen Description and Business Overview
 Table 77. Amgen Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Amgen Ustekinumab Biosimilars Product
 Table 79. Amgen Recent Developments/Updates
 Table 80. Samsung Bioepis Company Information
 Table 81. Samsung Bioepis Description and Business Overview
 Table 82. Samsung Bioepis Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. Samsung Bioepis Ustekinumab Biosimilars Product
 Table 84. Samsung Bioepis Recent Developments/Updates
 Table 85. Sandoz Company Information
 Table 86. Sandoz Description and Business Overview
 Table 87. Sandoz Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Sandoz Ustekinumab Biosimilars Product
 Table 89. Sandoz Recent Developments/Updates
 Table 90. Biocon Biologics Company Information
 Table 91. Biocon Biologics Description and Business Overview
 Table 92. Biocon Biologics Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. Biocon Biologics Ustekinumab Biosimilars Product
 Table 94. Biocon Biologics Recent Developments/Updates
 Table 95. Celltrion Company Information
 Table 96. Celltrion Description and Business Overview
 Table 97. Celltrion Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. Celltrion Ustekinumab Biosimilars Product
 Table 99. Celltrion Recent Developments/Updates
 Table 100. Qyuns Therapeutics Company Information
 Table 101. Qyuns Therapeutics Description and Business Overview
 Table 102. Qyuns Therapeutics Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. Qyuns Therapeutics Ustekinumab Biosimilars Product
 Table 104. Qyuns Therapeutics Recent Developments/Updates
 Table 105. Bio-Thera Solutions Company Information
 Table 106. Bio-Thera Solutions Description and Business Overview
 Table 107. Bio-Thera Solutions Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 108. Bio-Thera Solutions Ustekinumab Biosimilars Product
 Table 109. Bio-Thera Solutions Recent Developments/Updates
 Table 110. Huadong Medicine Company Information
 Table 111. Huadong Medicine Description and Business Overview
 Table 112. Huadong Medicine Ustekinumab Biosimilars Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 113. Huadong Medicine Ustekinumab Biosimilars Product
 Table 114. Huadong Medicine Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Ustekinumab Biosimilars Distributors List
 Table 118. Ustekinumab Biosimilars Customers List
 Table 119. Ustekinumab Biosimilars Market Trends
 Table 120. Ustekinumab Biosimilars Market Drivers
 Table 121. Ustekinumab Biosimilars Market Challenges
 Table 122. Ustekinumab Biosimilars Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Ustekinumab Biosimilars
 Figure 2. Global Ustekinumab Biosimilars Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Ustekinumab Biosimilars Market Share by Type: 2023 & 2030
 Figure 4. Subcutaneous Injection Product Picture
 Figure 5. Intravenous Infusion Product Picture
 Figure 6. Global Ustekinumab Biosimilars Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Ustekinumab Biosimilars Market Share by Application: 2023 & 2030
 Figure 8. Crohn's Disease
 Figure 9. Ulcerative Colitis
 Figure 10. Plaque Psoriasis
 Figure 11. Psoriatic Arthritis
 Figure 12. Other
 Figure 13. Global Ustekinumab Biosimilars Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 14. Global Ustekinumab Biosimilars Market Size (2019-2030) & (US$ Million)
 Figure 15. Global Ustekinumab Biosimilars Sales (2019-2030) & (K Units)
 Figure 16. Global Ustekinumab Biosimilars Average Price (US$/Unit) & (2019-2030)
 Figure 17. Ustekinumab Biosimilars Report Years Considered
 Figure 18. Ustekinumab Biosimilars Sales Share by Manufacturers in 2023
 Figure 19. Global Ustekinumab Biosimilars Revenue Share by Manufacturers in 2023
 Figure 20. Global 5 and 10 Largest Ustekinumab Biosimilars Players: Market Share by Revenue in Ustekinumab Biosimilars in 2023
 Figure 21. Ustekinumab Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 22. Global Ustekinumab Biosimilars Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 23. North America Ustekinumab Biosimilars Sales Market Share by Country (2019-2030)
 Figure 24. North America Ustekinumab Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 25. United States Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Canada Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 27. Europe Ustekinumab Biosimilars Sales Market Share by Country (2019-2030)
 Figure 28. Europe Ustekinumab Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 29. Germany Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. France Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. U.K. Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Italy Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Russia Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 34. Asia Pacific Ustekinumab Biosimilars Sales Market Share by Region (2019-2030)
 Figure 35. Asia Pacific Ustekinumab Biosimilars Revenue Market Share by Region (2019-2030)
 Figure 36. China Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. Japan Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. South Korea Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. India Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. Australia Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. China Taiwan Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Southeast Asia Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 43. Latin America Ustekinumab Biosimilars Sales Market Share by Country (2019-2030)
 Figure 44. Mexico Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Brazil Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Argentina Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Colombia Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 48. Middle East and Africa Ustekinumab Biosimilars Sales Market Share by Country (2019-2030)
 Figure 49. Middle East and Africa Ustekinumab Biosimilars Revenue Market Share by Country (2019-2030)
 Figure 50. Turkey Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. Saudi Arabia Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. UAE Ustekinumab Biosimilars Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 53. Global Sales Market Share of Ustekinumab Biosimilars by Type (2019-2030)
 Figure 54. Global Revenue Market Share of Ustekinumab Biosimilars by Type (2019-2030)
 Figure 55. Global Ustekinumab Biosimilars Price (US$/Unit) by Type (2019-2030)
 Figure 56. Global Sales Market Share of Ustekinumab Biosimilars by Application (2019-2030)
 Figure 57. Global Revenue Market Share of Ustekinumab Biosimilars by Application (2019-2030)
 Figure 58. Global Ustekinumab Biosimilars Price (US$/Unit) by Application (2019-2030)
 Figure 59. Ustekinumab Biosimilars Value Chain
 Figure 60. Ustekinumab Biosimilars Production Process
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Ustekinumab Market Research Report 2024
Global Psoriasis Biosimilar Market Research Report 2024
Global Rituximab Biosimilars Market Research Report 2025
Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Stelara Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Adalimumab Monoclonal Antibody Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tocilizumab Biosimilars Market Research Report 2024
Remicade Infliximab and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infliximab Injection Market Research Report 2024
Global Monoclonal antibodies mAbs Biosimilars Market Research Report 2024
Global Biosimilar Antibodies Market Research Report 2024
Global Arthritis Monoclonal Antibodies Market Research Report 2024
Enbrel Etanercept and Biosimilar Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti TNF α Monoclonal Antibody Market Insights Forecast to 2030
Global Adalimumab Infliximab And Etanercept Biosimilars Market Research Report 2024
Remicade infliximab Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Biosimilars Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Tocilizumab Drugs Market Research Report 2024
Global Adalimumab Drug Market Research Report 2024
Global Ranibizumab Drugs and Biosimilars Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions